• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合分子医学工具对与COVID-19症状相关的血液pH值分析

Blood pH Analysis in Combination with Molecular Medical Tools in Relation to COVID-19 Symptoms.

作者信息

Siebert Hans-Christian, Eckert Thomas, Bhunia Anirban, Klatte Nele, Mohri Marzieh, Siebert Simone, Kozarova Anna, Hudson John W, Zhang Ruiyan, Zhang Ning, Li Lan, Gousias Konstantinos, Kanakis Dimitrios, Yan Mingdi, Jiménez-Barbero Jesús, Kožár Tibor, Nifantiev Nikolay E, Vollmer Christian, Brandenburger Timo, Kindgen-Milles Detlef, Haak Thomas, Petridis Athanasios K

机构信息

RI-B-NT-Research Institute of Bioinformatics and Nanotechnology, Schauenburgerstr. 116, 24118 Kiel, Germany.

Department of Chemistry and Biology, University of Applied Sciences Fresenius, Limburger Str. 2, 65510 Idstein, Germany.

出版信息

Biomedicines. 2023 May 11;11(5):1421. doi: 10.3390/biomedicines11051421.

DOI:
10.3390/biomedicines11051421
PMID:37239092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10216059/
Abstract

The global outbreak of SARS-CoV-2/COVID-19 provided the stage to accumulate an enormous biomedical data set and an opportunity as well as a challenge to test new concepts and strategies to combat the pandemic. New research and molecular medical protocols may be deployed in different scientific fields, e.g., glycobiology, nanopharmacology, or nanomedicine. We correlated clinical biomedical data derived from patients in intensive care units with structural biology and biophysical data from NMR and/or CAMM (computer-aided molecular modeling). Consequently, new diagnostic and therapeutic approaches against SARS-CoV-2 were evaluated. Specifically, we tested the suitability of incretin mimetics with one or two pH-sensitive amino acid residues as potential drugs to prevent or cure long-COVID symptoms. Blood pH values in correlation with temperature alterations in patient bodies were of clinical importance. The effects of biophysical parameters such as temperature and pH value variation in relation to physical-chemical membrane properties (e.g., glycosylation state, affinity of certain amino acid sequences to sialic acids as well as other carbohydrate residues and lipid structures) provided helpful hints in identifying a potential Achilles heel against long COVID. In silico CAMM methods and in vitro NMR experiments (including P NMR measurements) were applied to analyze the structural behavior of incretin mimetics and SARS-CoV fusion peptides interacting with dodecylphosphocholine (DPC) micelles. These supramolecular complexes were analyzed under physiological conditions by H and P NMR techniques. We were able to observe characteristic interaction states of incretin mimetics, SARS-CoV fusion peptides and DPC membranes. Novel interaction profiles (indicated, e.g., by P NMR signal splitting) were detected. Furthermore, we evaluated GM1 gangliosides and sialic acid-coated silica nanoparticles in complex with DPC micelles in order to create a simple virus host cell membrane model. This is a first step in exploring the structure-function relationship between the SARS-CoV-2 spike protein and incretin mimetics with conserved pH-sensitive histidine residues in their carbohydrate recognition domains as found in galectins. The applied methods were effective in identifying peptide sequences as well as certain carbohydrate moieties with the potential to protect the blood-brain barrier (BBB). These clinically relevant observations on low blood pH values in fatal COVID-19 cases open routes for new therapeutic approaches, especially against long-COVID symptoms.

摘要

严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)/冠状病毒病2019(COVID-19)的全球大流行提供了一个积累大量生物医学数据集的平台,也带来了测试抗击这一流行病的新概念和策略的机遇与挑战。新的研究和分子医学方案可能会在不同的科学领域得到应用,例如糖生物学、纳米药理学或纳米医学。我们将重症监护病房患者的临床生物医学数据与来自核磁共振(NMR)和/或计算机辅助分子建模(CAMM)的结构生物学及生物物理数据进行了关联。因此,对针对SARS-CoV-2的新诊断和治疗方法进行了评估。具体而言,我们测试了具有一个或两个pH敏感氨基酸残基的肠促胰岛素类似物作为预防或治疗长期COVID症状的潜在药物的适用性。与患者体内温度变化相关的血液pH值具有临床重要性。诸如温度和pH值变化等生物物理参数相对于物理化学膜特性(例如糖基化状态、某些氨基酸序列对唾液酸以及其他碳水化合物残基和脂质结构的亲和力)的影响,为确定针对长期COVID的潜在致命弱点提供了有益的线索。应用计算机辅助分子建模方法和体外核磁共振实验(包括磷核磁共振测量)来分析肠促胰岛素类似物和SARS-CoV融合肽与十二烷基磷酸胆碱(DPC)胶束相互作用的结构行为。通过氢核磁共振和磷核磁共振技术在生理条件下对这些超分子复合物进行了分析。我们能够观察到肠促胰岛素类似物、SARS-CoV融合肽和DPC膜的特征性相互作用状态。检测到了新的相互作用谱(例如通过磷核磁共振信号分裂表明)。此外,我们评估了与DPC胶束复合的GM1神经节苷脂和唾液酸包被的二氧化硅纳米颗粒,以创建一个简单的病毒宿主细胞膜模型。这是探索SARS-CoV-2刺突蛋白与在半乳糖凝集素中发现的碳水化合物识别域具有保守pH敏感组氨酸残基的肠促胰岛素类似物之间结构-功能关系的第一步。所应用的方法有效地鉴定了具有保护血脑屏障(BBB)潜力的肽序列以及某些碳水化合物部分。这些关于致命COVID-19病例中低血液pH值的临床相关观察结果为新的治疗方法开辟了道路,特别是针对长期COVID症状的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/ec8e886897f0/biomedicines-11-01421-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/60654c6278f8/biomedicines-11-01421-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/1c7850e03619/biomedicines-11-01421-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/2fef9e010dbd/biomedicines-11-01421-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/a35b7afce4b5/biomedicines-11-01421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/55fe0696f245/biomedicines-11-01421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/1d701d030cb8/biomedicines-11-01421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/faf0b6fc1da0/biomedicines-11-01421-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/a5318c11e158/biomedicines-11-01421-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/9a6f9f494023/biomedicines-11-01421-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/ddfa157496be/biomedicines-11-01421-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/5d21062d1ec9/biomedicines-11-01421-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/0591dede7db2/biomedicines-11-01421-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/2e87bafa69e5/biomedicines-11-01421-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/da755541e9e2/biomedicines-11-01421-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/ec8e886897f0/biomedicines-11-01421-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/60654c6278f8/biomedicines-11-01421-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/1c7850e03619/biomedicines-11-01421-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/2fef9e010dbd/biomedicines-11-01421-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/a35b7afce4b5/biomedicines-11-01421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/55fe0696f245/biomedicines-11-01421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/1d701d030cb8/biomedicines-11-01421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/faf0b6fc1da0/biomedicines-11-01421-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/a5318c11e158/biomedicines-11-01421-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/9a6f9f494023/biomedicines-11-01421-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/ddfa157496be/biomedicines-11-01421-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/5d21062d1ec9/biomedicines-11-01421-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/0591dede7db2/biomedicines-11-01421-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/2e87bafa69e5/biomedicines-11-01421-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/da755541e9e2/biomedicines-11-01421-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e4/10216059/ec8e886897f0/biomedicines-11-01421-g012.jpg

相似文献

1
Blood pH Analysis in Combination with Molecular Medical Tools in Relation to COVID-19 Symptoms.结合分子医学工具对与COVID-19症状相关的血液pH值分析
Biomedicines. 2023 May 11;11(5):1421. doi: 10.3390/biomedicines11051421.
2
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.SARS-CoV-2 进化适应宿主进入和识别病毒-宿主相互作用中受体 O-乙酰神经氨酸糖基化。
Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.
3
NMR structures and localization of the potential fusion peptides and the pre-transmembrane region of SARS-CoV: Implications in membrane fusion.严重急性呼吸综合征冠状病毒潜在融合肽和跨膜前区域的核磁共振结构及定位:对膜融合的影响
Biochim Biophys Acta. 2015 Feb;1848(2):721-30. doi: 10.1016/j.bbamem.2014.11.025. Epub 2014 Dec 2.
4
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.羟氯喹和阿奇霉素联合治疗 SARS-CoV-2 的协同抗病毒作用:病毒-宿主相互作用的分子动力学研究揭示了什么。
Int J Antimicrob Agents. 2020 Aug;56(2):106020. doi: 10.1016/j.ijantimicag.2020.106020. Epub 2020 May 13.
5
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.结构和分子建模研究揭示了氯喹和羟氯喹抗 SARS-CoV-2 感染的新作用机制。
Int J Antimicrob Agents. 2020 May;55(5):105960. doi: 10.1016/j.ijantimicag.2020.105960. Epub 2020 Apr 3.
6
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
7
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
8
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.羟氯喹和阿奇霉素联合对抗 SARS-CoV-2 的协同抗病毒作用:病毒-宿主相互作用的分子动力学研究揭示了什么。
Int J Antimicrob Agents. 2020 Aug;56(2):106020. doi: 10.1016/j.ijantimicag.2020.106020. Epub 2020 May 13.
9
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.SARS-CoV-2 刺突蛋白与人 ACE2 受体相互作用的蛋白质结构分析:从构象变化到新型中和抗体。
Cell Mol Life Sci. 2021 Feb;78(4):1501-1522. doi: 10.1007/s00018-020-03580-1. Epub 2020 Jul 4.
10
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.

引用本文的文献

1
Insights into the baseline blood pH homeostasis at admission and the risk of in-hospital mortality in COVID-19 patients.探讨 COVID-19 患者入院时的基础血液 pH 值平衡和院内死亡率风险。
Biomark Med. 2024;18(19):795-800. doi: 10.1080/17520363.2024.2395800. Epub 2024 Sep 10.

本文引用的文献

1
Effect of β-hydroxybutyrate on behavioral alterations, molecular and morphological changes in CNS of multiple sclerosis mouse model.β-羟基丁酸对多发性硬化小鼠模型中枢神经系统行为改变、分子及形态学变化的影响
Front Aging Neurosci. 2022 Dec 1;14:1075161. doi: 10.3389/fnagi.2022.1075161. eCollection 2022.
2
Post-COVID syndrome, inflammation, and diabetes.新冠后综合征、炎症与糖尿病。
J Diabetes Complications. 2022 Nov;36(11):108336. doi: 10.1016/j.jdiacomp.2022.108336. Epub 2022 Oct 6.
3
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
靶向刺突蛋白发夹前中间体的未经修饰肽对 SARS-CoV-2 感染的纳摩尔抑制作用。
Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2210990119. doi: 10.1073/pnas.2210990119. Epub 2022 Sep 19.
4
HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R/STAT3/NF-κB65/NLRP3 Activation.HDAC3 抑制剂 RGFP966 通过下调 P2X7R/STAT3/NF-κB65/NLRP3 激活来改善由 Cuprizone 诱导的脱髓鞘小鼠模型和 LPS 刺激的 BV2 细胞中的神经炎症。
ACS Chem Neurosci. 2022 Sep 7;13(17):2579-2598. doi: 10.1021/acschemneuro.1c00826. Epub 2022 Aug 10.
5
Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies.胰高血糖素样肽-1受体激动剂作为潜在的诱导髓鞘形成和抗脱髓鞘疗法
Front Cell Dev Biol. 2022 Jul 6;10:950623. doi: 10.3389/fcell.2022.950623. eCollection 2022.
6
The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.SARS-CoV-2 刺突蛋白 S1 亚基激活人单核细胞产生与 COVID-19 相关的细胞因子:与半乳糖凝集素-3 的相关性。
Front Immunol. 2022 Mar 22;13:831763. doi: 10.3389/fimmu.2022.831763. eCollection 2022.
7
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes.基于肠降血糖素的药物治疗在肥胖和糖尿病治疗方面的最新进展。
Front Endocrinol (Lausanne). 2022 Mar 1;13:838410. doi: 10.3389/fendo.2022.838410. eCollection 2022.
8
Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design.肽对病毒膜融合的抑制作用及肽设计方法
Pathogens. 2021 Dec 9;10(12):1599. doi: 10.3390/pathogens10121599.
9
Evidence for Quantum Chemical Effects in Receptor-Ligand Binding Between Integrin and Collagen Fragments - A Computational Investigation With an Impact on Tissue Repair, Neurooncolgy and Glycobiology.整合素与胶原蛋白片段之间受体-配体结合中量子化学效应的证据——对组织修复、神经肿瘤学和糖生物学有影响的计算研究
Front Mol Biosci. 2021 Nov 16;8:756701. doi: 10.3389/fmolb.2021.756701. eCollection 2021.
10
Molecular Recognition Insights of Sialic Acid Glycans by Distinct Receptors Unveiled by NMR and Molecular Modeling.通过核磁共振和分子建模揭示不同受体对唾液酸聚糖的分子识别见解
Front Mol Biosci. 2021 Nov 15;8:727847. doi: 10.3389/fmolb.2021.727847. eCollection 2021.